Four Myths About Addiction Rehab That Simply Aren’t True

Addiction Rehab Myths

Addiction levels are rising at a rapid rate across the UK at present, from Leeds to London, Bournemouth to Bradford, we’re seeing spikes in the number of people abusing the likes of alcohol, cocaine and opiods.

Many experts are calling it a crisis, while we’re seeing more people seeking help and checking in to a private alcohol rehab centre for treatment. However, others aren’t quite ready to take that step, often put off by the myths that surround rehab.

Even in 2023 there’s still this stigma around rehab, as if it’s only for certain people. But that’s simply not true. So, while the country lies in addiction crisis, here are four myths that need debunking in order for more people to reach out and get the help they need…

Rehab is just for severe addiction

Firstly, there is this preconception that rehab is only for people that really get “off their heads” on drugs, or spend their days from 9am until 9pm at night drinking. This simply isn’t true. Addiction takes all forms, and all forms need treating in order to improve a person’s life.

Rehabs address all manner of people with addictions, from those who feel they are only just starting to develop a problem, to those who are functioning users at a weekend but feel their relationship is unhealthy.

Just because a person doesn’t pass out on the street drunk, doesn’t mean they don’t need rehabilitation treatment.

It costs an unaffordable amount of money

One of the big put offs people have with rehab is the amount of money it costs, or they think it costs. While some treatment centres aren’t cheap, there are affordable options for people, as well as things like payment plans that can be set up and grants that can be applied for.

There’s help out there for people to ensure they get the treatment they need, while rehab can also be gotten on the NHS if the addiction is so severe.

Of course, it is an investment, but if you were to total the amount that someone would spend on alcohol or drugs for the rest of their life compared to how much would be spent on rehab and getting clean, then it’s a no brainer.

You’re locked in a room to go cold turkey

Often people are reluctant to enter rehab as they view it as almost some form of prison. It’s absolutely not, and today there are plenty of home comforts and tons going on within them. It’s not a case of being made to sweat it out and you’re sent on your way, there’s all manner of therapy options, from family therapy to equine therapy, art therapy and music therapy. Everything is tailored to a patient’s needs.

The food is healthy, and you’re given a full structure that will not only get you through rehab, but is designed to be followed in recovery too, giving patience the best chance to stay sober when they reenter the real world.

If you get through rehab, you’re cured!

Finally, there’s also a preconception that if you leave rehab having done your full programme, you’re cured. That’s by no means the case, and people are never cured from addiction.

Someone will always be an alcoholic, for example, but they manage that more effectively in sobriety. That’s why you need structure and planning for the rest of your life to stay on track and limit the chances of relapse.

Do that, and a successful recovery phase of addiction can last forever.

Rehab isn’t as scary as the myths make out. It can be a truly life changing experience for the better, and if you’re struggling, it can be just a phone call away too.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version